53 related articles for article (PubMed ID: 24139873)
21. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S
J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258
[TBL] [Abstract][Full Text] [Related]
22. Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal.
Wang Q; Yu T; Yuan Y; Zhuang H; Wang Z; Liu X; Feng M
J Surg Oncol; 2013 Mar; 107(4):422-7. PubMed ID: 22833259
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of radiation sensitivity, delay of proliferative recovery after radiation and abrogation of MAPK (p44/42) signaling by imatinib in glioblastoma cells.
Quick QA; Gewirtz DA
Int J Oncol; 2006 Aug; 29(2):407-12. PubMed ID: 16820883
[TBL] [Abstract][Full Text] [Related]
24. Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3.
Huang CY; Lin CS; Tai WT; Hsieh CY; Shiau CW; Cheng AL; Chen KF
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):456-62. PubMed ID: 23474115
[TBL] [Abstract][Full Text] [Related]
25. High-dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison.
Tanaka M; Ino Y; Nakagawa K; Tago M; Todo T
Lancet Oncol; 2005 Dec; 6(12):953-60. PubMed ID: 16321763
[TBL] [Abstract][Full Text] [Related]
26. The anti-tumor role and mechanism of integrated and truncated PDCD5 proteins in osteosarcoma cells.
Han XR; Sun Y; Bai XZ
Cell Signal; 2012 Aug; 24(8):1713-21. PubMed ID: 22560879
[TBL] [Abstract][Full Text] [Related]
27. Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.
Sprinzl MF; Reisinger F; Puschnik A; Ringelhan M; Ackermann K; Hartmann D; Schiemann M; Weinmann A; Galle PR; Schuchmann M; Friess H; Otto G; Heikenwalder M; Protzer U
Hepatology; 2013 Jun; 57(6):2358-68. PubMed ID: 23424039
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological concentrations of ascorbate radiosensitize glioblastoma multiforme primary cells by increasing oxidative DNA damage and inhibiting G2/M arrest.
Herst PM; Broadley KW; Harper JL; McConnell MJ
Free Radic Biol Med; 2012 Apr; 52(8):1486-93. PubMed ID: 22342518
[TBL] [Abstract][Full Text] [Related]
29. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
30. Influence of imatinib mesylate on radiosensitivity of astrocytoma cells.
Ranza E; Bertolotti A; Facoetti A; Mariotti L; Pasi F; Ottolenghi A; Nano R
Anticancer Res; 2009 Nov; 29(11):4575-8. PubMed ID: 20032406
[TBL] [Abstract][Full Text] [Related]
31. Stimulatory effects of sorafenib on human non‑small cell lung cancer cells in vitro by regulating MAPK/ERK activation.
Zhang YN; Wu XY; Zhong N; Deng J; Zhang L; Chen W; Li X; Zhong CJ
Mol Med Rep; 2014 Jan; 9(1):365-9. PubMed ID: 24213303
[TBL] [Abstract][Full Text] [Related]
32. The effects of diphenylhydantoin on murine astrocytoma radiosensitivity.
Lordo CD; Stroude EC; Del Maestro RF
J Neurooncol; 1987; 5(4):339-50. PubMed ID: 3440876
[TBL] [Abstract][Full Text] [Related]
33. Astrocytoma Treated by Radiotherapy: Death from Acute Leukaemia: Clinical Pathological Conference.
Hewer TF
Med J Southwest; 1957 Apr; 72(2):67-72. PubMed ID: 28907881
[No Abstract] [Full Text] [Related]
34. Sensitizing glioblastoma to radiotherapy.
Crunkhorn S
Nat Rev Drug Discov; 2021 Aug; 20(8):588. PubMed ID: 34234306
[No Abstract] [Full Text] [Related]
35. Synergistic Effect of Quercetin Magnetite Nanoparticles and Targeted Radiotherapy in Treatment of Breast Cancer.
Askar MA; El-Nashar HA; Al-Azzawi MA; Rahman SSA; Elshawi OE
Breast Cancer (Auckl); 2022; 16():11782234221086728. PubMed ID: 35359610
[TBL] [Abstract][Full Text] [Related]
36. Genes Involved in the PD-L1 Pathway Might Associate with Radiosensitivity of Patients with Gastric Cancer.
Du Z; Yan D; Li Z; Gu J; Tian Y; Cao J; Tang Z
J Oncol; 2020; 2020():7314195. PubMed ID: 32963532
[TBL] [Abstract][Full Text] [Related]
37. Plasmon-Enhanced Controlled Drug Release from Ag-PMA Capsules.
Neri G; Corsaro C; Fazio E
Molecules; 2020 May; 25(9):. PubMed ID: 32403460
[TBL] [Abstract][Full Text] [Related]
38. Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines.
Riedel M; Struve N; Müller-Goebel J; Köcher S; Petersen C; Dikomey E; Rothkamm K; Kriegs M
Oncotarget; 2016 Sep; 7(38):61988-61995. PubMed ID: 27542273
[TBL] [Abstract][Full Text] [Related]
39. Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models.
Daudigeos-Dubus E; Le Dret L; Lanvers-Kaminsky C; Bawa O; Opolon P; Vievard A; Villa I; Pagès M; Bosq J; Vassal G; Zopf D; Geoerger B
PLoS One; 2015; 10(11):e0142612. PubMed ID: 26599335
[TBL] [Abstract][Full Text] [Related]
40. 3,3'-Diindolylmethane: A Promising Sensitizer of γ-Irradiation.
Wang W; Lv M; Huangfu C; Wang F; Zhang J
Biomed Res Int; 2015; 2015():465105. PubMed ID: 26579534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
